Results 51 to 60 of about 10,738 (252)
Water-in-Water Emulsion as a New Approach to Produce Mesalamine-Loaded Xylan-Based Microparticles
Applied Sciences, 2019 The water-in-water emulsion method has been reported as a technique able to prepare microparticles without using harmful solvents. However, there are few reports showing the encapsulation of small molecules into microparticles produced within this ...
Bartolomeu S. Souza +6 more
doaj +1 more source
Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU
United European Gastroenterology Journal, EarlyView.ABSTRACT Background Leishmaniasis (LI) is a vector‐borne illness caused by a protozoan of the genus Leishmania. Data on the features of LI in patients with inflammatory bowel disease (IBD) are scarce. Aim To describe the characteristics of patients with IBD who present with leishmaniasis, infection outcomes and the risk factors associated with ...
L Madero‐Velázquez +29 more
wiley +1 more source
Prevalence, predictors, and clinical consequences of medical adherence in IBD: How to improve it? [PDF]
, 2009 Inflammatory bowel diseases (IBD) are chronic diseases with a relapsing-remitting disease course necessitating lifelong treatment. However, non-adherence has been reported in over 40% of patients, especially those in remission taking maintenance ...
Lakatos, Péter László
core +2 more sources
Clinical Pharmacology: Advances and Applications, 2019 Abhijeet Jakate,1 Brian McNamee,2 Donald Burkindine31Clinical Pharmacology, Allergan plc, Madison, NJ, USA; 2Clinical Pharmacology, Allergan Biologics Ltd, Liverpool, UK; 3QPS Bio-Kinetic, Springfield, MO, USAObjective: Delayed-release mesalamine 400 mg ...
Jakate A, McNamee B, Burkindine D
doaj
Differential diagnosis problem of pulmonary changes in ulcerative colitis [PDF]
Vojnosanitetski Pregled, 2010 Introduction. Inflammatory intestinal diseases are often accompanied with extraintestinal and even pulmonary manifestations. The treatment of these intestinal diseases includes sulphasalazine and mesalazine, which may have undesirable allergic and other ...
Đurić Mirna +3 more
doaj +1 more source
Isolated fever induced by mesalamine treatment
World Journal of Gastroenterology, 2013 Adverse reactions to mesalamine, a treatment used to induce and maintain remission in inflammatory bowel diseases, particularly ulcerative colitis, have been described in the literature as case reports. This case illustrates an unusual adverse reaction.
Roy Nasnas +7 more
openaire +2 more sources
United European Gastroenterology Journal, EarlyView.ABSTRACT Background The international bowel ultrasound group‐segmental activity score (IBUS‐SAS) is a validated tool with high interobserver agreement for accurately detecting disease activity in Crohn's disease (CD). Here, we addressed whether the IBUS‐SAS is also suitable to assess disease activity in ulcerative colitis (UC). Methods The IBUS‐SAS and
Sarah Fischer +11 more
wiley +1 more source
Second Korean Guideline for the Management of Ulcerative Colitis [PDF]
, 2017 Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by a relapsing and remitting course. The direct and indirect costs of the treatment of UC are high, and the quality of life of patients is reduced, especially during ...
���������
core +1 more source
BMC Gastroenterology, 2013 Background Although high non-adherence to medication has been noticed for ulcerative colitis (UC), little is known about adherence to mesalamine treatments and determinants that can predict adherence.
Lachaine Jean +3 more
doaj +1 more source
mSphere, 2020 Colibactin induces DNA damage in mammalian cells and has been linked to the virulence of Escherichia coli and the promotion of colorectal cancer (CRC). By looking for mutants attenuated in the promoter activity of clbB encoding one of the key enzymes for
Min Tang-Fichaux +5 more
doaj +1 more source